Tianjing Li

ORCID: 0000-0001-5371-4558
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Meta-analysis and systematic reviews
  • Health Systems, Economic Evaluations, Quality of Life
  • Glaucoma and retinal disorders
  • Retinal and Optic Conditions
  • Retinal Diseases and Treatments
  • Delphi Technique in Research
  • Corneal surgery and disorders
  • Ophthalmology and Visual Impairment Studies
  • Ocular Surface and Contact Lens
  • Retinal Imaging and Analysis
  • Clinical practice guidelines implementation
  • Cerebral Venous Sinus Thrombosis
  • Statistical Methods in Clinical Trials
  • Health Sciences Research and Education
  • Health Policy Implementation Science
  • Balance, Gait, and Falls Prevention
  • Ethics in Clinical Research
  • Allergic Rhinitis and Sensitization
  • scientometrics and bibliometrics research
  • Traumatic Brain Injury Research
  • Health and Medical Research Impacts
  • Intraocular Surgery and Lenses
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Pain Management and Placebo Effect
  • Dermatology and Skin Diseases

Johns Hopkins University
2015-2025

University of Colorado Anschutz Medical Campus
2015-2025

University of Colorado Denver
2015-2025

Colorado School of Public Health
2020-2025

St. Michael's Hospital
2025

Zhejiang University
2022-2024

Zhejiang University of Science and Technology
2024

Weatherford College
2023

Yancheng Institute of Technology
2023

State Key Laboratory of Modern Optical Instruments
2022

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review done, what authors did, they found. Over past decade, advances methodology terminology have necessitated an update guideline. PRISMA 2020 statement replaces 2009 includes new reporting guidance that reflects methods identify, select, appraise, synthesise studies. structure presentation of items been...

10.1136/bmj.n71 article EN cc-by BMJ 2021-03-29

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review done, what authors did, they found. Over past decade, advances methodology terminology have necessitated an update guideline. PRISMA 2020 statement replaces 2009 includes new reporting guidance that reflects methods identify, select, appraise, synthesise studies. structure presentation of items been...

10.1186/s13643-021-01626-4 article EN cc-by Systematic Reviews 2021-03-29

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review done, what authors did, they found. Over past decade, advances methodology terminology have necessitated an update guideline. PRISMA 2020 statement replaces 2009 includes new reporting guidance that reflects methods identify, select, appraise, synthesise studies. structure presentation of items been...

10.1016/j.ijsu.2021.105906 article EN cc-by International Journal of Surgery 2021-03-28

The methods and results of systematic reviews should be reported in sufficient detail to allow users assess the trustworthiness applicability review findings. Preferred Reporting Items for Systematic Meta-Analyses (PRISMA) statement was developed facilitate transparent complete reporting has been updated (to PRISMA 2020) reflect recent advances methodology terminology. Here, we present explanation elaboration paper 2020, where explain why each item is recommended, bullet points that...

10.1136/bmj.n160 article EN cc-by BMJ 2021-03-29

Background: The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement, published in 2009, was designed to help systematic reviewers transparently report why the review done, what authors did they found. Over last decade, there have been many advances methodology terminology, which necessitated an update guideline.Objectives: To develop PRISMA 2020 statement reporting reviews.Methods: We reviewed 60 documents with guidance generate suggested modifications 2009...

10.31222/osf.io/v7gm2 preprint EN 2020-09-14

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review done, what authors did, they found. Over past decade, advances methodology terminology have necessitated an update guideline. PRISMA 2020 statement replaces 2009 includes new reporting guidance that reflects methods identify, select, appraise, synthesise studies. structure presentation of items been...

10.1016/j.jclinepi.2021.03.001 article EN cc-by Journal of Clinical Epidemiology 2021-03-29

Network meta-analysis (NMA), combining direct and indirect comparisons, is increasingly being used to examine the comparative effectiveness of medical interventions. Minimal guidance exists on how rate quality evidence supporting treatment effect estimates obtained from NMA. We present a four-step approach in each direct, indirect, NMA based methods developed by GRADE working group. Using an example published NMA, we show that varies high very low across ratings given whole network are...

10.1136/bmj.g5630 article EN BMJ 2014-09-24

La declaración PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses), publicada en 2009, se diseñó para ayudar a los autores de revisiones sistemáticas documentar manera transparente el porqué la revisión, qué hicieron y encontraron. Durante última década, ha habido muchos avances metodología terminología las sistemáticas, lo que requerido una actualización esta guía. prisma 2020 sustituye 2009 e incluye nueva guía presentación publicaciones refleja métodos identificar,...

10.1016/j.recesp.2021.06.016 article ES cc-by-nc-nd Revista Española de Cardiología 2021-07-21

The methods and results of systematic reviews should be reported in sufficient detail to allow users assess the trustworthiness applicability review findings. Preferred Reporting Items for Systematic Meta-Analyses (PRISMA) statement was developed facilitate transparent complete reporting has been updated (to PRISMA 2020) reflect recent advances methodology terminology. Here, we present explanation elaboration paper 2020, where explain why each item is recommended, bullet points that...

10.31222/osf.io/gwdhk preprint EN 2020-09-14

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review done, what authors did, they found. Over past decade, advances methodology terminology have necessitated an update guideline. PRISMA 2020 statement replaces 2009 includes new reporting guidance that reflects methods identify, select, appraise, synthesise studies. structure presentation of items been...

10.1016/j.rec.2021.07.010 article EN cc-by-nc-nd Revista Española de Cardiología (English Edition) 2021-08-23

10.1007/s11739-016-1583-7 article EN Internal and Emergency Medicine 2016-12-02

Evidence shows the quality of reporting randomised controlled trials is not optimal. The lack transparent impedes readers from judging reliability and validity trial findings, prevents researchers extracting information for systematic reviews, results in research waste. Consolidated Standards Reporting Trials (CONSORT) statement was developed to improve trials. primary focus on parallel group with two treatment groups. Crossover are a particular type chronic conditions which participants...

10.1136/bmj.l4378 article EN cc-by-nc BMJ 2019-07-31

To develop a reporting guideline for overviews of reviews healthcare interventions.Development the preferred items (PRIOR) statement.Core team (seven individuals) led day-to-day operations, and an expert advisory group (three provided methodological advice. A panel 100 experts (authors, editors, readers including members public or patients) was invited to participate in modified Delphi exercise. 11 panellists (chosen on basis expertise, representing relevant stakeholder groups) were take...

10.1136/bmj-2022-070849 article EN cc-by-nc BMJ 2022-08-09

Abstract Network meta-analysis, in the context of a systematic review, is meta-analysis which multiple treatments (that is, three or more) are being compared using both direct comparisons interventions within randomized controlled trials and indirect across based on common comparator. To ensure validity findings from network meta-analyses, review must be designed rigorously conducted carefully. Aspects designing conducting for include defining question, specifying eligibility criteria,...

10.1186/1741-7015-9-79 article EN cc-by BMC Medicine 2011-06-27

Background: The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement, published in 2009, was designed to help systematic reviewers transparently report why the review done, what authors did they found. Over last decade, there have been many advances methodology terminology, which necessitated an update guideline.Objectives: To develop PRISMA 2020 statement reporting reviews.Methods: We reviewed 60 documents with guidance generate suggested modifications 2009...

10.31222/osf.io/v7gm2_v1 preprint EN 2020-09-14

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review done, what authors did, they found. Over past decade, advances methodology terminology have necessitated an update guideline. PRISMA 2020 statement replaces 2009 includes new reporting guidance that reflects methods identify, select, appraise, synthesise studies. structure presentation of items been...

10.26633/rpsp.2022.112 article EN cc-by-nc-nd Revista Panamericana de Salud Pública 2022-12-29
Coming Soon ...